MedPath

MDI Therapeutics, Inc.

MDI Therapeutics, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2016-01-01
Employees
1
Market Cap
-
Website
http://www.mditherapeutics.com

SAD Evaluation of Safety, Tolerability, PK, and PD of MDI-2517 in Healthy Participants

Phase 1
Completed
Conditions
Safety and Tolerability
Interventions
Other: Placebo
First Posted Date
2024-06-12
Last Posted Date
2025-03-14
Lead Sponsor
MDI Therapeutics, Inc.
Target Recruit Count
48
Registration Number
NCT06453824
Locations
🇺🇸

1951 NW 7th Avenue, Suite 180, Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath